Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-22-012221

Chief Executive Officer sold 5,675 shares at $232.41 ($1,318,947)

  • Chief Executive Officer acquired 5,675 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Farrell Michael J. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-04-18 Exercise or conversion : show line 1 in the form +5,675 $57.76 $327,788 410,904 D
2022-04-18 Sale : show line 2 in the form −5,675 $232.41 $1,318,947 405,229 D
Open-market sales · 5,675 sh · avg $232.41 · $1,318,947

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-18 Exercise or conversion : show line 3 in the form ResMed Common Stock Options −5,675 111,290 D
Loading xslF345X03/form4.xml…